載入...
Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct
Renovascular disease (RVD) induces renal microvascular (MV) rarefaction that drives progressive kidney injury. In previous studies, we showed that renal vascular endothelial growth factor (VEGF) therapy attenuated MV damage, but did not resolve renal injury at practical clinical doses. To increase t...
Na minha lista:
| 發表在: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Nephrology
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884109/ https://ncbi.nlm.nih.gov/pubmed/26541349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015040346 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|